Bioavailability: Difference between revisions
Feedback

From WikiLectures

(minor)
(minor)
Line 11: Line 11:


'''Absolute bioavailability'''
'''Absolute bioavailability'''
[[File:AUC_IVPO.svg| right | 250px |]]
[[File:AUC_IVPO.svg| right|250px|The plasma concentration (C) over time (t) graph]]
:It is the comparison of the per os F to the intravenous F
:It is the comparison of the per os F to the intravenous F
::<math> {F_{abs}} = {AUC_{P.O.} \times D_{I.V.}\over AUC_{I.V.}\times D_{P.O.}} </math>
::<math> {F_{abs}} = {AUC_{P.O.} \times D_{I.V.}\over AUC_{I.V.}\times D_{P.O.}} </math>

Revision as of 01:28, 5 July 2014

Definition

Bioavailability (F) is a pharmacokinetic parameter representing the fraction of a drug dose that reaches the systemic circulation unaltered.

Characteristics

  • The greater the F, the greater the amount of drug that reaches the systemic circulation, and thus the greater the drug concentration in plasma and vice versa
  • The route with the highest F (F=1) is via intravenous (I.V.) administration.
  • The second highest F is achieved through inhalation.
  • The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing *first pass metabolism, prior entering to the systemic circulation.

Types

Absolute bioavailability

The plasma concentration (C) over time (t) graph
It is the comparison of the per os F to the intravenous F
where
AUCP.O.: area under the curve for the oral route
AUCI.V.: area under the curve for the intravenous route
DP.O.: dose administered from oral route
DI.V.: dose administers from intravenous route

Relative bioavailability

It is the comparison of the per os F to another administration route, other than intravenous.